SEI Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.43M | Buy |
150,264
+47,107
| +46% | +$366K | ﹤0.01% | 2175 |
|
|
2025
Q4 | $805K | Sell |
103,157
-259,059
| -72% | -$1.87M | ﹤0.01% | 2277 |
|
|
2025
Q3 | $2.75M | Buy |
362,216
+138,973
| +62% | +$1.16M | ﹤0.01% | 1568 |
|
|
2025
Q2 | $2M | Buy |
223,243
+113,776
| +104% | +$1.06M | ﹤0.01% | 1651 |
|
|
2025
Q1 | $821K | Buy |
109,467
+52,277
| +91% | +$422K | ﹤0.01% | 1983 |
|
|
2024
Q4 | $430K | Buy |
57,190
+1,537
| +3% | +$11.7K | ﹤0.01% | 2235 |
|
|
2024
Q3 | $423K | Buy |
55,653
+13,806
| +33% | +$105K | ﹤0.01% | 2238 |
|
|
2024
Q2 | $259K | Sell |
41,847
-385
| -0.9% | -$2.13K | ﹤0.01% | 2391 |
|
|
2024
Q1 | $215K | Buy |
42,232
+3,070
| +8% | +$17.3K | ﹤0.01% | 2408 |
|
|
2023
Q4 | $235K | Buy |
39,162
+1,156
| +3% | +$6.7K | ﹤0.01% | 2399 |
|
|
2023
Q3 | $269K | Buy |
38,006
+11,011
| +41% | +$79.1K | ﹤0.01% | 2340 |
|
|
2023
Q2 | $190K | Sell |
26,995
-16,509
| -38% | -$132K | ﹤0.01% | 2486 |
|
|
2023
Q1 | $363K | Sell |
43,504
-28,906
| -40% | -$278K | ﹤0.01% | 2260 |
|
|
2022
Q4 | $831K | Buy |
72,410
+46,227
| +177% | +$576K | ﹤0.01% | 1830 |
|
|
2022
Q3 | $330K | Sell |
26,183
-3,233
| -11% | -$41.6K | ﹤0.01% | 2267 |
|
|
2022
Q2 | $311K | Sell |
29,416
-49,237
| -63% | -$508K | ﹤0.01% | 2305 |
|
|
2022
Q1 | $1.28M | Buy |
78,653
+42,925
| +120% | +$689K | ﹤0.01% | 1725 |
|
|
2021
Q4 | $495K | Sell |
35,728
-44,405
| -55% | -$588K | ﹤0.01% | 2108 |
|
|
2021
Q3 | $1.15M | Sell |
80,133
-38,604
| -33% | -$609K | ﹤0.01% | 1733 |
|
|
2021
Q2 | $1.88M | Buy |
+118,737
| New | +$1.61M | ﹤0.01% | 1541 |
|
|
2020
Q3 | – | Sell |
-94,898
| Closed | -$452K | – | 2409 |
|
|
2020
Q2 | $452K | Buy |
+94,898
| New | +$379K | ﹤0.01% | 1900 |
|
|
2019
Q2 | – | Sell |
-59,358
| Closed | -$483K | – | 2416 |
|
|
2019
Q1 | $483K | Sell |
59,358
-16,472
| -22% | -$141K | ﹤0.01% | 1907 |
|
|
2018
Q4 | $612K | Buy |
+75,830
| New | +$590K | ﹤0.01% | 1697 |
|
|
2018
Q3 | – | Sell |
-588
| Closed | -$4K | – | 2562 |
|
|
2018
Q2 | $4K | Hold |
588
| – | – | ﹤0.01% | 3188 |
|
|
2018
Q1 | $3K | Hold |
588
| – | – | ﹤0.01% | 3146 |
|
|
2017
Q4 | $3K | Hold |
588
| – | – | ﹤0.01% | 3022 |
|
|
2017
Q3 | $3K | Buy |
588
+146
| +33% | +$748 | ﹤0.01% | 2909 |
|
|
2017
Q2 | $2K | Hold |
442
| – | – | ﹤0.01% | 2854 |
|
|
2017
Q1 | $4K | Hold |
442
| – | – | ﹤0.01% | 2605 |
|
|
2016
Q4 | $3K | Hold |
442
| – | – | ﹤0.01% | 2652 |
|
|
2016
Q3 | $2K | Hold |
442
| – | – | ﹤0.01% | 2633 |
|
|
2016
Q2 | $1K | Buy |
+442
| New | +$1.37K | ﹤0.01% | 2526 |
|
|
2015
Q4 | – | Sell |
-27,734
| Closed | -$316K | – | 2528 |
|
|
2015
Q3 | $316K | Buy |
+27,734
| New | +$370K | ﹤0.01% | 1459 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC